tiprankstipranks
Trending News
More News >
JW (Cayman) Therapeutics Co. Ltd. (HK:2126)
:2126

Compare JW (Cayman) Therapeutics Co. Ltd. (2126) vs. Competitors

Compare
1 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
JW (Cayman) Therapeutics Co. Ltd.
HK$2.50
HK$1.01B
-1.48
74.10%
Alphamab Oncology
HK$9.58
HK$8.68B
33.97
175.00%
2 Buy
0 Hold
0 Sell
Moderate Buy
Lepu Biopharma Co. Ltd. Class H
HK$4.98
HK$8.66B
-41.39
70.70%
Jiangsu Recbio Technology Co., Ltd. Class H
HK$4.18
HK$2.40B
-3.40
-39.57%
CStone Pharmaceuticals
HK$5.34
HK$7.80B
-17.23
129.49%
Shandong Boan Biotechnology Company., Limited. Class H
HK$8.33
HK$5.18B
134.79
-4.25%

Performance Comparison

Ticker
Company Name
Price
Change
% Change
HK:2126
JW (Cayman) Therapeutics Co. Ltd.
2.42
1.01
71.63%
HK:9966
Alphamab Oncology
8.91
5.58
167.57%
HK:2157
Lepu Biopharma Co. Ltd. Class H
4.66
1.77
61.25%
HK:2179
Jiangsu Recbio Technology Co., Ltd. Class H
5.01
-3.34
-40.00%
HK:2616
CStone Pharmaceuticals
5.37
3.14
140.81%
HK:6955
Shandong Boan Biotechnology Company., Limited. Class H
8.33
-0.37
-4.25%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts